anonymous
Guest
anonymous
Guest
but does anyone have a 40% share yet?Public schools have failed our children
but does anyone have a 40% share yet?Public schools have failed our children
I do! I’m currently at 53%! Suck it you nerd!but does anyone have a 40% share yet?
i hsve 54%! Suck it nerd hater!I do! I’m currently at 53%! Suck it you nerd!
right, right. Sure helps to define the market the way you want and use the measure you want. Congrats big baller.I do! I’m currently at 53%! Suck it you nerd!
Thank you! Obviously it was not true when it was said that they hired the “best of the best” because you’re here. Guess a tough sell is not your strength!right, right. Sure helps to define the market the way you want and use the measure you want. Congrats big baller.
Thank you! Obviously it was not true when it was said that they hired the “best of the best” because you’re here. Guess a tough sell is not your strength!
takes one to know oneThank you! Obviously it was not true when it was said that they hired the “best of the best” because you’re here. Guess a tough sell is not your strength!
Sincerely, there are many areas of the country with very little O, never took off. The reps with the high O should be the ones we focus on. The rest have to figure out how to grow it another waybut does anyone have a 40% share yet?
Just pull the plug already on all of bms, derm is not the disease, it’s just the symptomwhy do we continue to target Otezla? Makes about as much sense as attacking generic topicals.
those two products are getting used first because they are safe. they are simple. and is some patients, they are effective.
instead, we should be targeting everyone else as to why we should be the logical step between Otezla and injectables. look, in about 120 days after any Otezla start, about 60% fail.
our marketing and our positioning fail. miserable leadership.
you can always tell the amateurs in dermatology when they attack topicals. phrases like topical churn. topical cycling, etc are created by no nothing analysts from ZS and then picked up my no nothing career marketers than could sell a damn thing except themselves to goons inside PPK
Spot MF'ing on!why do we continue to target Otezla? Makes about as much sense as attacking generic topicals.
those two products are getting used first because they are safe. they are simple. and is some patients, they are effective.
instead, we should be targeting everyone else as to why we should be the logical step between Otezla and injectables. look, in about 120 days after any Otezla start, about 60% fail.
our marketing and our positioning fail. miserable leadership.
you can always tell the amateurs in dermatology when they attack topicals. phrases like topical churn. topical cycling, etc are created by no nothing analysts from ZS and then picked up my no nothing career marketers than could sell a damn thing except themselves to goons inside PPK
This is the flavor that they savor up here, neighbor!If you want to understand how derm providers think and prescribe then you need to get some of them to work with you on the brand team. Hire a MD dermatologist, a dermatology PA or a dermatology NP who actually sees and treats patients with psoriasis. You don't need a feedback board. They are useful as long as you are paying them for the day. These prescribers may be the ONLY ones who can drive this brand forward if it can be driven at all. BMS will have to come off of their salary quotas. Most MD derms out of medical school start off at $450k a year and any experienced derm PA or NP will bring home close to $300k a year. The most successful dermatology brands I know have actually providers on the marketing team. Just a thought for BMY.
Hell, I'd just like a marketer or two or maybe even senior sales leadership to regularly meet with derm KOLs instead of spend all their energies manipulating the KPIs.If you want to understand how derm providers think and prescribe then you need to get some of them to work with you on the brand team. Hire a MD dermatologist, a dermatology PA or a dermatology NP who actually sees and treats patients with psoriasis. You don't need a feedback board. They are useful as long as you are paying them for the day. These prescribers may be the ONLY ones who can drive this brand forward if it can be driven at all. BMS will have to come off of their salary quotas. Most MD derms out of medical school start off at $450k a year and any experienced derm PA or NP will bring home close to $300k a year. The most successful dermatology brands I know have actually providers on the marketing team. Just a thought for BMY.
You realize we did have a Derm PA on staff for launch right?If you want to understand how derm providers think and prescribe then you need to get some of them to work with you on the brand team. Hire a MD dermatologist, a dermatology PA or a dermatology NP who actually sees and treats patients with psoriasis. You don't need a feedback board. They are useful as long as you are paying them for the day. These prescribers may be the ONLY ones who can drive this brand forward if it can be driven at all. BMS will have to come off of their salary quotas. Most MD derms out of medical school start off at $450k a year and any experienced derm PA or NP will bring home close to $300k a year. The most successful dermatology brands I know have actually providers on the marketing team. Just a thought for BMY.
What happened to the PA? Obviously whomever it was did not have enough experience with psoriasis to understand the prescribing habits of their peers.You realize we did have a Derm PA on staff for launch right?